Melanoma Re-excision Study: Testing Observation Without Surgery
Part of Cancer, Skin clinical trials.
This study tests whether patients with moderate-thickness skin melanoma need additional surgery after their initial tumor removal, or if careful monitoring alone is enough. The goal is to avoid unnecessary surgery while keeping patients safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with cutaneous (skin) melanoma, stage pT1b to pT4b, either superficial spreading or nodular type
- Initial tumor already removed with at least 1 mm clear margin around it
- Good overall health (able to manage daily activities with minimal assistance)
- Life expectancy of at least 5 years from diagnosis (not counting the melanoma)
- Willing to commit to regular follow-up appointments and monitoring
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This trial tests whether patients with stage 3 melanoma that shrinks significantly after initial immunotherapy can safely avoid having all their lymph nodes surgically removed. Instead, only the main affected node is removed for testing.
This study compares different ways to manage newly diagnosed melanoma in older adults. It looks at how well surgery plus lymph node biopsy works and how it affects quality of life.
This trial compares having one surgery to remove extra skin around a thin melanoma versus the standard two-step approach (biopsy first, then a wider excision later). It aims to see if one surgery is just as safe and reduces the number of procedures.
This trial tests whether removing a clinically involved lymph node basin (via a specific lymph node excision surgery) after certain melanoma findings is helpful. It mainly aims to see effects on outcomes and on arm/leg swelling (lymphedema) after surgery.
This study follows adults with certain melanoma stages to better understand the disease over time. You may be asked to share tissue samples (if available) so researchers can study tumor biology and track outcomes.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.